Enrollment open for a study of an investigational insulin

January 15, 2020

The team at Lilly Diabetes Care are currently seeking children and adolescents with type 1 diabetes to participate in a multinational clinical trial. Participants must be on multiple daily injections using an insulin pen or syringe. This study will compare an investigational ultra-rapid insulin to current treatment in controlling blood sugars. Find criteria and other details on this downloadable PDF.

Study participants should meet the following criteria at study start:

  • Are at least 1 to <18 years of age
  • Diagnosed with type 1 diabetes for at least 6 months and do not currently use an insulin pump
  • Treated with long-acting insulin once or twice daily and rapid-acting insulin at mealtimes for at least 90 days
  • Have an A1C between 6.5% and 9.5%

If you and your child are interested in participating, study site locations and contact information along with further details may be found at the following website: